InvestSMART

Raptor Metals Ltd (ASX: RAP) - Announcements

Current share price for RAP : $0.030 0.003 (9.09%)+

ASX company news and announcements for Raptor Metals Ltd (RAP) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Raptor Metals Ltd (RAP) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Raptor Metals Ltd (RAP), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Raptor Metals Ltd (RAP)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$12 ResApp Receives Approval to Begin Adult Study 14 Dec 2015 9:21AM $0.088 $0.030 fallen by 65.91%
$12 Release of Restricted Securities 4 Dec 2015 10:13AM $0.082 $0.030 fallen by 63.41%
$12 Result of Annual General Meeting 30 Nov 2015 6:13PM $0.075 $0.030 fallen by 60%
$12 CEO Presentation at Canary Networks Investor Roadshow 25 Nov 2015 8:29AM $0.092 $0.030 fallen by 67.39%
$12 Becoming a substantial holder 16 Nov 2015 8:31AM $0.135 $0.030 fallen by 77.78%
$12 US Roadshow - Investor Presentation 11 Nov 2015 9:28AM $0.090 $0.030 fallen by 66.67%
$12 Further Positive Preliminary Results from Clinical Study 10 Nov 2015 9:15AM $0.078 $0.030 fallen by 61.54%
$12 Trading Halt 6 Nov 2015 9:08AM $0.078 $0.030 fallen by 61.54%
$12 Exhibitor at McKinsey Global Integrated Care Conference 4 Nov 2015 8:27AM $0.075 $0.030 fallen by 60%
$12 Appendix 4C - quarterly 30 Oct 2015 9:25AM $0.084 $0.030 fallen by 64.29%
$12 Notice of Annual General Meeting/Proxy Form 28 Oct 2015 6:59PM $0.066 $0.030 fallen by 54.55%
$12 Dr Abeyratne to present at Pneumonia Innovations Summit 22 Oct 2015 9:26AM $0.039 $0.030 fallen by 23.08%
$12 TechKnow Invest Roadshow Presentation 20 Oct 2015 8:28AM $0.033 $0.030 fallen by 9.09%
$12 Change of Director's Interest Notice 12 Oct 2015 10:14AM $0.035 $0.030 fallen by 14.29%
$12 Australia Biotech Invest Presentation 6 Oct 2015 8:26AM $0.035 $0.030 fallen by 14.29%
$12 Appendix 4G 1 Oct 2015 8:36AM $0.036 $0.030 fallen by 16.67%
$12 Annual Report 2015 1 Oct 2015 8:36AM $0.036 $0.030 fallen by 16.67%
$12 Positive Preliminary Results from Current Clinical Study 30 Sep 2015 9:03AM $0.035 $0.030 fallen by 14.29%
$12 Trading Halt 28 Sep 2015 9:01AM $0.035 $0.030 fallen by 14.29%
$12 Appendix 3B 23 Sep 2015 5:19PM $0.030 $0.030 fallen by 0%
$12 Investor Presentation 16 Sep 2015 8:42AM $0.020 $0.030 risen by 50%
$12 FDA Consultant Engagement 3 Sep 2015 8:25AM $0.018 $0.030 risen by 66.67%
$12 Clinical Study Update 1 Sep 2015 8:29AM $0.016 $0.030 risen by 87.50%
$12 Preliminary Final Report 31 Aug 2015 5:41PM $0.016 $0.030 risen by 87.50%
$12 Second Site Added To Clinical Study 12 Aug 2015 8:28AM $0.023 $0.030 risen by 30.43%

526 - 550 of 568 results

Page 22 of 23

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.